Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children, 6737-6738 [E7-2362]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 29 / Tuesday, February 13, 2007 / Notices
6737
ANNUAL BURDEN ESTIMATES
Number of responses per
respondent
Average burden hours per
response
51
35
16
30
1
1
1
1
0.333333
1.0
0.3
1.0
17.0
35.0
4.8
30.0
Administrator ....................................................................................................
Supervisor ........................................................................................................
Line Staff ..........................................................................................................
Partner Organization ........................................................................................
Observation ......................................................................................................
6
12
18
12
12
1
1
1
1
1
1.5
1.0
1.0
1.0
........................
9.0
12.0
18.0
12.0
........................
Estimated Total Annual Burden Hours: ....................................................
........................
........................
........................
137.8
Number of respondents
Instrument
Total burden
hours
Survey of States
Stage
Stage
Stage
Stage
1:
2:
3:
4:
State Survey .....................................................................................
Interview State TANF Director with Diversion Program ...................
Interview State TANF Director without Diversion Program ..............
Interview Local TANF Administrator .................................................
Site Visit Protocols
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. E-mail
address: infocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after the publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: February 7, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–632 Filed 2–12–07; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jlentini on PROD1PC65 with NOTICES
Health Resources and Services
Administration
Advisory Committee on Heritable
Disorders and Genetic Diseases in
Newborns and Children
Health Resources and Services
Administration (HRSA), HHS.
AGENCY:
VerDate Aug<31>2005
16:55 Feb 12, 2007
Jkt 211001
Notice of request for
nominations.
ACTION:
SUMMARY: The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill eight (8)
vacancies on the Advisory Committee
on Heritable Disorders and Genetic
Diseases in Newborns and Children.
Authority: Section 1111 of the PHS Act, 42
U.S.C. 300b–10. The Committee is governed
by the provisions of Public Law 92–463, as
amended (5 U.S.C. App. 2), and 41 CFR Part
102–3, which sets forth standards for the
formation and use of advisory committees.
The agency must receive
nominations on or before March 15,
2007.
DATES:
All nominations are to be
submitted to Michele A. Lloyd-Puryear,
M.D., Ph.D., Designated Federal Official
and Executive Secretary, Advisory
Committee on Heritable Disorders and
Genetic Diseases in Newborns and
Children, and Chief, Genetic Services
Branch, Maternal and Child Health
Bureau, Health Resources and Services
Administration, Room 18A–19,
Parklawn Building, 5600 Fishers Lane,
Rockville, Maryland 20857.
Nominations will not be accepted by email or facsimilie.
FOR FURTHER INFORMATION CONTACT: Ms.
Jill F. Shuger, Genetic Services Branch,
Maternal and Child Health Bureau,
HRSA, at jshuger@hrsa.gov or (301)
443–1080. A copy of the Committee
Charter and list of the current
membership can be obtained by
contacting Ms. Shuger or by accessing
the Advisory Committee Web site at
https://mchb.hrsa.gov/programs/
genetics/committee.
SUPPLEMENTARY INFORMATION: Title XXVI
of the Children’s Health Act of 2000,
‘‘Screening for Heritable Disorders,’’
ADDRESSES:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
established a program to improve the
ability of States to provide newborn and
child screening for heritable disorders.
Title XXVI enacts three sections of the
Public Health Service (PHS) Act:
Sections 1109, 1110, and 1111. The
Secretary of Health and Human Services
(HHS) is directed under section 1111 of
the PHS Act to establish an Advisory
Committee on Heritable Disorders in
Newborns and Children (Committee).
HHS has expanded the Committee to
include genetic diseases and has
renamed the Committee accordingly.
The Committee is established to
advise and guide the Secretary regarding
the most appropriate application of
universal newborn screening tests,
technologies, policies, guidelines and
programs for effectively reducing
morbidity and mortality in newborns
and children having or at risk for
heritable disorders. In addition, the
Committee provides advice and
recommendations to the Secretary
concerning the grants and projects
authorized under section 1109 and
technical information to develop
policies and priorities for this Program
that will enhance the ability of the State
and local health agencies to provide for
newborn and child screening,
counseling and health care services for
newborns and children having or at risk
for heritable disorders.
Specifically, HRSA is requesting
nominations for eight voting members to
serve on the Committee. Members shall
be selected from medical, technical,
public health or scientific professionals
with special expertise in the field of
heritable disorders or in providing
screening, counseling, testing or
specialty services for newborns and
children at risk for heritable disorders
and from members of the public having
E:\FR\FM\13FEN1.SGM
13FEN1
jlentini on PROD1PC65 with NOTICES
6738
Federal Register / Vol. 72, No. 29 / Tuesday, February 13, 2007 / Notices
special expertise about or concern with
heritable disorders.
The individuals selected for
appointment to the Committee can be
invited to serve for overlapping terms of
up to 4 years. However, any member
appointed to fill a vacancy of an
unexpired term shall be appointed for
the remainder of such term. Members
may serve after the expiration of their
term until their successors have taken
office. Terms of more than 2 years are
contingent upon the renewal of the
Committee by appropriate action prior
to its expiration. Members who are not
Federal employees will receive a
stipend for each day they are engaged in
the performance of their duties as
members of the Committee. Members
shall receive per diem and travel
expenses as authorized by Section 5
U.S.C. 5703 for persons employed
intermittently in Government service.
Members who are officers or employees
of the United States Government shall
not receive compensation for service on
the Committee. Nominees will be
invited to serve beginning from
September 30, 2007.
To allow the Secretary to choose from
a highly qualified list of potential
candidates, more than one nomination
is requested per open position.
Nominations should be typewritten. The
following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee and appears
to have no conflict of interest that
would preclude the Committee
membership—potential candidates will
be asked to provide detailed information
concerning consultancies, research
grants, or contracts to permit evaluation
of possible sources of conflicts of
interest; (2) the nominator’s name,
address, and daytime telephone
number, and the home/or work address,
telephone number, and e-mail address
of the individual being nominated; and
(3) a current copy of the nominee’s
curriculum vitae. Please submit
nominations no later than March 15,
2007.
To the extent practicable, members of
the Committee should have expertise in
dealing with heritable disorders and
genetic diseases that affect the racial
and ethnic and geographical diversity of
newborns served by the State newborn
screening programs. The Department of
Health and Human Services will ensure
VerDate Aug<31>2005
16:55 Feb 12, 2007
Jkt 211001
that the membership of the Committee
reflects an equitable geographical and
gender distribution, provided that the
effectiveness of the Committee would
not be impaired. Appointments shall be
made without discrimination on the
basis of age, ethnicity, gender, sexual
orientation, and cultural, religious, or
socioeconomic status.
Dated: February 6, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–2362 Filed 2–12–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Poison Control Centers Stabilization
and Enhancement Program
Health Resources and Services
Administration, HHS.
ACTION: Notice; request for public
comment.
AGENCY:
SUMMARY: The Health Resources and
Services Administration (HRSA) is
seeking comments from the public on its
plan to institute a permanent deviation
from a policy in the Department of
Health and Human Services (HHS),
Grants Policy Directive (GPD) 3.01
governing indirect cost recovery for one
of its grant programs. The GPD states
‘‘HHS considers activities conducted by
grantees that result in indirect charges a
necessary and appropriate part of HHS
grants, and HHS awarding offices must
reimburse their share of these costs.’’
Although HRSA typically reimburses
grantees for their full share of
administrative overhead represented in
approved indirect cost rates (which can
be up to 50 percent), the agency
believes, in the case of its Poison
Control Program, that full recovery of
overhead expenditures would be
detrimental to the poison control
centers (PCCs) funded under the
program because of the financial
instability of PCCs. The purpose of the
HRSA Poison Control Centers
Stabilization and Enhancement Grant
Program is to assist PCCs in achieving
financial stability, preventing
poisonings and providing treatment
recommendations for poisonings.
Limiting indirect costs is necessary
because many PCCs are located within
institutions such as universities and
hospitals that have established indirect
cost rates in the range of 30 to 50
percent. It is in the best interest of PCCs
to limit the indirect cost recovery to 10
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
percent, leaving 90 percent of the grant
funds to achieve the objectives of the
grant program. This limitation would be
applicable to all awardees of the Poison
Control Center Stabilization and
Enhancement Grant Programs.
DATES: If you wish to comment on any
portion of this notice, HRSA must
receive comments by March 15, 2007.
ADDRESSES: You may submit comments
by any of the following methods:
• E-mail: lroche@hrsa.gov. Include
‘‘Poison Control Stabilization and
Enhancement Program’’ in the subject
line of the message.
• Mail: Lori Roche, Division of
Healthcare Preparedness, Healthcare
Systems Bureau, Health Resources and
Services Administration (HRSA), 5600
Fishers Lane, Room 13–103, Rockville,
MD 20857.
• Hand Delivery/Courier: Lori Roche,
Division of Healthcare Preparedness,
Healthcare Systems Bureau, Health
Resources and Services Administration
(HRSA), 5600 Fishers Lane, Room 13–
103, Rockville, MD 20857.
Docket: For access to the docket to
read background documents or
comments received, go to the Division
of Healthcare Preparedness, Healthcare
Systems Bureau, Health Resources and
Services Administration (HRSA), 5600
Fishers Lane, Room 13–103, Rockville,
Maryland, 20857, weekdays between the
hours of 8:30 a.m. and 5 p.m. To
schedule an appointment to view public
comments, phone (301) 443–0652.
FOR FURTHER INFORMATION CONTACT: Lori
Roche, at the above address, telephone
number 301–443–0652.
SUPPLEMENTARY INFORMATION: The
Health Resources and Services
Administration’s (HRSA) Poison Control
Program (PCP) was established in
February 2000 under the Poison Center
Enhancement and Awareness Act, Pub.
L. 106–174. The program was
reauthorized in 2003 under the Poison
Control Center Enhancement and
Awareness Act, Amendments of 2003,
Pub. L. 108–194. This Act authorizes
funding to maintain the national tollfree number; establish a nationwide
media campaign to promote poison
control center (PCC) utilization;
maintain the PCC grant program;
develop standardized poison prevention
and poison control promotion programs;
develop standard patient management
guidelines for commonly encountered
toxic exposures; improve and expand
the poison control data collection
activities; improve national toxic
exposure surveillance by enhancing
activities at the Centers for Disease
Control and Prevention and the Agency
for Toxic Substances and Disease
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 72, Number 29 (Tuesday, February 13, 2007)]
[Notices]
[Pages 6737-6738]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-2362]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Heritable Disorders and Genetic Diseases in
Newborns and Children
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice of request for nominations.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations to fill eight (8) vacancies on the Advisory
Committee on Heritable Disorders and Genetic Diseases in Newborns and
Children.
Authority: Section 1111 of the PHS Act, 42 U.S.C. 300b-10. The
Committee is governed by the provisions of Public Law 92-463, as
amended (5 U.S.C. App. 2), and 41 CFR Part 102-3, which sets forth
standards for the formation and use of advisory committees.
DATES: The agency must receive nominations on or before March 15, 2007.
ADDRESSES: All nominations are to be submitted to Michele A. Lloyd-
Puryear, M.D., Ph.D., Designated Federal Official and Executive
Secretary, Advisory Committee on Heritable Disorders and Genetic
Diseases in Newborns and Children, and Chief, Genetic Services Branch,
Maternal and Child Health Bureau, Health Resources and Services
Administration, Room 18A-19, Parklawn Building, 5600 Fishers Lane,
Rockville, Maryland 20857. Nominations will not be accepted by e-mail
or facsimilie.
FOR FURTHER INFORMATION CONTACT: Ms. Jill F. Shuger, Genetic Services
Branch, Maternal and Child Health Bureau, HRSA, at jshuger@hrsa.gov or
(301) 443-1080. A copy of the Committee Charter and list of the current
membership can be obtained by contacting Ms. Shuger or by accessing the
Advisory Committee Web site at https://mchb.hrsa.gov/programs/genetics/
committee.
SUPPLEMENTARY INFORMATION: Title XXVI of the Children's Health Act of
2000, ``Screening for Heritable Disorders,'' established a program to
improve the ability of States to provide newborn and child screening
for heritable disorders. Title XXVI enacts three sections of the Public
Health Service (PHS) Act: Sections 1109, 1110, and 1111. The Secretary
of Health and Human Services (HHS) is directed under section 1111 of
the PHS Act to establish an Advisory Committee on Heritable Disorders
in Newborns and Children (Committee). HHS has expanded the Committee to
include genetic diseases and has renamed the Committee accordingly.
The Committee is established to advise and guide the Secretary
regarding the most appropriate application of universal newborn
screening tests, technologies, policies, guidelines and programs for
effectively reducing morbidity and mortality in newborns and children
having or at risk for heritable disorders. In addition, the Committee
provides advice and recommendations to the Secretary concerning the
grants and projects authorized under section 1109 and technical
information to develop policies and priorities for this Program that
will enhance the ability of the State and local health agencies to
provide for newborn and child screening, counseling and health care
services for newborns and children having or at risk for heritable
disorders.
Specifically, HRSA is requesting nominations for eight voting
members to serve on the Committee. Members shall be selected from
medical, technical, public health or scientific professionals with
special expertise in the field of heritable disorders or in providing
screening, counseling, testing or specialty services for newborns and
children at risk for heritable disorders and from members of the public
having
[[Page 6738]]
special expertise about or concern with heritable disorders.
The individuals selected for appointment to the Committee can be
invited to serve for overlapping terms of up to 4 years. However, any
member appointed to fill a vacancy of an unexpired term shall be
appointed for the remainder of such term. Members may serve after the
expiration of their term until their successors have taken office.
Terms of more than 2 years are contingent upon the renewal of the
Committee by appropriate action prior to its expiration. Members who
are not Federal employees will receive a stipend for each day they are
engaged in the performance of their duties as members of the Committee.
Members shall receive per diem and travel expenses as authorized by
Section 5 U.S.C. 5703 for persons employed intermittently in Government
service. Members who are officers or employees of the United States
Government shall not receive compensation for service on the Committee.
Nominees will be invited to serve beginning from September 30, 2007.
To allow the Secretary to choose from a highly qualified list of
potential candidates, more than one nomination is requested per open
position. Nominations should be typewritten. The following information
should be included in the package of material submitted for each
individual being nominated for consideration: (1) A letter of
nomination that clearly states the name and affiliation of the nominee,
the basis for the nomination (i.e., specific attributes which qualify
the nominee for service in this capacity), and a statement that the
nominee is willing to serve as a member of the Committee and appears to
have no conflict of interest that would preclude the Committee
membership--potential candidates will be asked to provide detailed
information concerning consultancies, research grants, or contracts to
permit evaluation of possible sources of conflicts of interest; (2) the
nominator's name, address, and daytime telephone number, and the home/
or work address, telephone number, and e-mail address of the individual
being nominated; and (3) a current copy of the nominee's curriculum
vitae. Please submit nominations no later than March 15, 2007.
To the extent practicable, members of the Committee should have
expertise in dealing with heritable disorders and genetic diseases that
affect the racial and ethnic and geographical diversity of newborns
served by the State newborn screening programs. The Department of
Health and Human Services will ensure that the membership of the
Committee reflects an equitable geographical and gender distribution,
provided that the effectiveness of the Committee would not be impaired.
Appointments shall be made without discrimination on the basis of age,
ethnicity, gender, sexual orientation, and cultural, religious, or
socioeconomic status.
Dated: February 6, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7-2362 Filed 2-12-07; 8:45 am]
BILLING CODE 4165-15-P
